Guangzhou Yueyang Pharmaceutical Development

Guangzhou Yueyang Pharmaceutical is a clinical-stage specialty pharmaceutical company focused on the development of high-end modified-release oral dosage forms. Founded by Dr. Winston Sun, the company utilizes its proprietary controlled-release technology platforms to develop 505(b)(2) products that offer improved safety and efficacy over existing therapies. Their pipeline primarily targets chronic conditions such as pain management, cardiovascular diseases, and metabolic disorders. The company operates R&D centers in both Guangzhou, China, and the United States, positioning itself to address global regulatory standards and markets.